Table of Contents Table of Contents
Previous Page  671 860 Next Page
Information
Show Menu
Previous Page 671 860 Next Page
Page Background

given the storm of aggressive changes within the prostate

gland

( Fig. 4 )

. Importantly, we show that the presence of

nimbosus

is associated with aggression to otherwise

morphologically indolent prostate tumors.

Examples of field-wide changes in prostate cancer

include hypoxia within the microenvironment

[26]

, epithe-

lial-to-mesenchymal transition

[27]

, and even differential

androgen signaling

[28,29]

. Here, we showed that a diffuse

expression of

SChLAP1

was observed in situ in both

intratumoral glandular and variant (IDC/CA) components,

which further supports a common clonal ancestor to both

histopathologies. However, it remains speculative if the co-

occurrence of

SChLAP1

dysregulation and genomic insta-

bility represents early field-wide molecular aberrations

responsible for driving the development of clonal prome-

tastatic IDC/CA and glandular adenocarcinoma. The con-

cept of field cancerization leading to prostate

tumorigenesis is further backed by observation of high

levels of mutations in the adjacent normal prostate

epithelium, suggesting for ongoing mutational processes

[(Fig._3)TD$FIG]

Fig. 3 –

SChLAP1

is highly expressed in prostate cancers harboring intraductal carcinoma (IDC) and cribriform architecture (CA). (A) Volcano plot of

mRNA abundance of 156 tumors (Canadian cohort) showing differential gene expression between IDC/CA+ and IDC/CA– prostate cancers. (B) Box and

whisker (first/third quartiles

W

IQR) plot comparison of

SChLAP1

mRNA abundance between the two groups. (C) Independent validation of

SChLAP1

association with IDC/CA, using RNA-ISH (

I

5 signals cutoff) on tissue microarray (EMC cohort). (D) Diffuse

SChLAP1

RNA-ISH signals in CA subpathology

(open arrow) and adjacent invasive adenocarcinoma (closed arrows) support a field defect. (E) Biochemical relapse-free rate of Canadian cohort

stratified by combinatorial IDC/CA and

SChLAP1

(upper tertile cutoff), showing worst outcome in

SChLAP1+

, IDC/CA+ subgroup. EMC = Erasmus Medical

Center; FC = fold change; FDR = false discovery rate; IQR = interquartile range; RNA-ISH = RNA in situ hybridization.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 6 5 – 6 7 4

671